APPLICATION OF SIX SIGMA METRICS FOR INTERNAL QUALITY CONTROL OF HBV, HCV, AND HIV SCREENING BY ELECTROCHEMILUMINESCENCE AT THE NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION

Thị Thanh Dung Nguyễn1, , Văn Lợi Ngô1, Vân Chi Trần1, Ngọc Quế Trần1
1 Viện Huyết học – Truyền máu Trung ương

Main Article Content

Abstract

Background: Serological screening for HBV, HCV, and HIV is essential for blood safety. Traditional Westgard multirules for semi-quantitative assays often yield excessive false rejections and resource waste.


Objectives: To evaluate the analytical performance of ECLIA screening assays for HBV, HCV, and HIV using Six Sigma metrics.


Methods: A retrospective, cross-sectional study analyzed positive internal quality control (IQC) data of HBsAg, anti-HCV, and HIV Ag/Ab assays across five Roche cobas e801 analyzers from July 2023 to December 2024. Allowable Total Error (%TEa) was calculated based on the cut-off distance method. Bias% was estimated against peer-group means via Cobas IT. Sigma values and customized Westgard multirules were determined.


Results: All assays on all five analyzers demonstrated world-class performance Sigma > 6. Consequently, IQC design was simplified to a single 13S rule (N=2) with a run size of 1,000 samples. This strategy reduced out-of-control troubleshooting events by 43.8%, from 32 instances under classic multirules to 18 instances under Westgard-Sigma).


Conclusion: Six Sigma metrics optimize IQC design for blood screening serology, substantially lowering false rejection rates while maintaining high diagnostic reliability.

Article Details

References

1. George A. Green, R. Neill Carey, James O. Westgard, et al. (1997), Quality control for qualitative assays: quantitative QC procedure designed to assure analytical quality required for an ELISA of hepatitis B surface antigen. Clinical Chemistry, 43:9, 1618–1621.
2. S. Walke, W. Dimech, P. Kiely, et al. (2009), An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories. Vox Sanguinis, 97(4), 309-316.
3. Wayne Dimech (2021), The Standardization and Control of Serology and Nucleic Acid Testing for Infectious Diseases. Clinical Microbiology Reviews, 34(4), e00035-21.
4. Joseph Litten (2016), Applying Sigma Metrics to Reduce Outliers. Clin Lab Med, 36(4), 741-752.
5. Greg Scheurich, Sonu Bhatnagar, and Sten Westgard (2024), Sigma metrics analysis of serology screening assays to enhance quality and efficiency in New Zealand blood services. Diagnostic Microbiology & Infectious Disease, 110(2024) 116451.
6. Sten Westgard (2020), Secrets of Better Sigma Metrics, Part Two, Westgard QC.
7. Sonu Bhatnagar, Sten Westgard, Nguyen Thi Thanh Dung, et al. (2024), Applying sigma metrics to assess quality control processes in the transfusion transmissible infection screening laboratory of a blood center. PLOS ONE, 19(10): e0312422.
8. Nguyễn Thị Thu Hà, Nguyễn Hoàng Phương, Phan Thị Thanh Nhàn, et al. (2022), Áp dụng thang Sigma trong đánh giá chất lượng xét nghiệm tại khoa sinh hoá, bệnh viện Bệnh Nhiệt đới Trung ương. Truyền nhiễm Việt Nam, 03(43).
9. Paulo Pereira, Quality control of qualitative tests for medical laboratories. 2019.
10. Westgard JO and Westgard SA (2016), Quality control review: implementing a scientifically based quality control system. Annals of Clinical Biochemistry, 53(1), 32-50.